Severe phenotype in infantile facioscapulohumeral muscular dystrophy

Neuromuscular Disorders

Volumn 16, Issue 9-10, 2006, Pages 553-558

  Klinge, Lars ^a   Eagle, Michelle ^a   Haggerty, Irene D ^a   Roberts, Catherine E ^a   Straub, Volker ^a   Bushby, Kate M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Facioscapulohumeral muscular dystrophy; Infantile onset; Muscular weakness

Indexed keywords

ADOLESCENT; ADULT; ALLELE; ARTICLE; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; FACE MUSCLE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HYPERLORDOSIS; HYPOVENTILATION; INFANT; LORDOSIS; MALE; MOSAICISM; MUSCLE ATROPHY; MUSCLE WEAKNESS; NOCTURNAL HYPOVENTILATION; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; RARE DISEASE; RISK ASSESSMENT;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; DISEASE PROGRESSION; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TESTING; HUMANS; INHERITANCE PATTERNS; LONGITUDINAL STUDIES; LORDOSIS; MALE; MOSAICISM; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MUSCULAR ATROPHY; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MUTATION; PHENOTYPE; PROGNOSIS; SEX DISTRIBUTION;

EID: 33748573261     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nmd.2006.06.008     Document Type: Article

References (26)

1. Tawil R., Figlewicz D.A., Griggs R.C., and Weiffenbach B. Facioscapulohumeral dystrophy: a distinct regional myopathy with a novel molecular pathogenesis. Ann Neurol 432 (1998) 279-282
2. Engel, and FranziniArmstrong. Myology. 3rd ed. (2004), McGraw-Hill, London pp. 1123-1133
3. Brooke M.H. A clinician's view of neuromuscular diseases (1977), Williams & Wilkins, Baltimore, Md
4. Brouwer O.F., Padberg G.W., Wijmenga C., and Frants R.R. Facioscapulohumeral muscular dystrophy in early childhood. Arch Neruol 51 (1994) 387-394
5. Padberg GW. Facioscapulohumeral muscular dystrophy: a clinician's experience. In: Upadhyaya M, Cooper DN (eds) Facioscapulohumeral muscular dystrophy: clinical medicine and molecular cell biology. New York: Garland Science, 2004; pp 41-54.
6. Brouwer O.F., Padberg G.W., Ruys C.J., et al. Hearing loss in facioscapulohumeral muscular dystrophy. Neurology 41 (1991) 1878-1881
7. Padberg G. Facioscapulohumeral disease (1982), University of Leiden, Leiden, Holland 243
8. Lunt P.W., Jardine P.E., Koch M.C., et al. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD). Hum Mol Genet 4 (1995) 951-958
9. Zatz M., Marie S.K., Cerqueira A., Vainzhoff M., Pavanello R.C., and Passos-Bueno M.R. The facioscapulohumeral muscular dystrophy (FSHD1) gene affects males more severely and more frequently than females. Am J Med Genet 77 (1998) 155-161
10. Wijmenga C., Hewitt J.E., Sandkuijl L.A., et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral dystrophy. Nat Genet 2 (1992) 26-30
11. Padberg G.W. Facioscapulohumeral muscular dystrophy. In: Emery A.E.H. (Ed). Neuromuscular disorders, clinical and molecular genetics (1998), Wiley, Chichester
12. Van der M., and Frants R.R. The D4Z4 repeat-mediated pathogenesis of facioscapulohumeral muscular dystrophy. Am J Hum Genet 76 (2005) 375-386
13. Tupler R., and Gabellini D. Molecular basis of facioscapulohumeral muscular dystrophy. Cell Mol Life Sci 61 (2004) 557-566
14. Wohlgemuth M., Lemmers R.J., van der Kooi E.L., et al. Possible phenotypic dosage effect in patients compound heterozyous for FSHD-sized 4q35 alleles. Neurology 61 (2003) 909-913
15. Deidda G., Cacurri S., Piazzo N., and Felicetti L. Direct detection of 4q35 rearrangements implicated in facioscapulohumeral muscular dystrophy (FSHD). J Med Genet 33 (1996) 361-365
16. Lemmers R.J.L., de Kievit P., van Geel M., et al. Complete allele information in the diagnosis of facioscapulohumeral muscular dystrophy by triple DNA analysis. Ann Neurol 50 (2001) 816-819
17. van Geel M., Dickson M.C., Beck A.F., et al. Genomic analysis of human chromosome 10q and 4q telomeres suggest a common origin. Genomics 79 (2002) 210-217
18. Lemmers R.J.L.F., Wohlgemuth M., Frants R.R., et al. Contractions of D4Z4 on 4qB do not cause facioscapulohumeral muscular dystrophy. Am J Hum Genet 75 (2004) 1124-1130
19. Bakker E., Van der Wielen M.J., Voorhoeve E., et al. Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: diagnostic approach for sporadic and familial cases. J Med Genet 33 (1996) 29-35
20. Jardine P.E., Koch M.C., Lunt P.W., et al. De novo facioscapulohumeral muscular dystrophy defined by DNA probe p13E-11 (D4F104S1). Arch Dis Child 71 (1994) 221-227
21. van der Maarel S.M., Deidda G., Lemmers R.J.L.F., et al. De novo facioscapulohumeral muscular dystrophy: frequent somatic mosaicism, sex-dependent phenotype, and the role of mitotic transchromosomal repeat interaction between chromosomes 4 and 10. Am J Hum Genet 66 (2000) 26-35
22. Kohler J., Rupilius B., Otto M., et al. Germline mosaicism in 4q35 facioscapulohumeral muscular dystrophy (FSHD 1A) occurring predominantly in oogenesis. Hum Genet 98 4 (1996) 485-490
23. Bailey R.O., Marzulo D.C., and Hans M.B. Infantile facioscapulohumeral muscular dystrophy: new observations. Acta Neurol Scand 74 (1986) 51-85
24. McGarry J., Garg B., and Silvert S. Death in childhood due to facioscapulohumeral muscular dystrophy. Acta Neurol Scand 68 (1983) 61-63
25. Wohlgemuth M., Van der Kooi E.L., Van Kesteren R.G., et al. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 63 (2004) 176-178
26. Wohlgemuth M., Van der Kooi E.L., Hendriks J.C., et al. Face mask spirometry and respiratory pressures in normal subjects. Eur Respir J 22 (2003) 1001-1006